ArticleClinical rheumatology2026
Urate-lowering therapy adherence among gout patients in Southwest China: A cross-sectional study of determinants and regional disparities.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveGout is directly associated with hyperuricemia. This study aims to investigate the adherence rate to urate-lowering therapy (ULT) and its influencing factors among patients with gout in Southwest China.
methodsA cross-sectional study was conducted involving 1023 gout patients treated at the Affiliated Hospital of Southwest Medical University between January 2022 and June 2025. Data were collected through telephone follow-ups and electronic medical record reviews. The Adherence to Refills and Medications Scale (ARMS) was used to assess ULT adherence among gout patients. A multivariate binary logistic regression model was used to analyze the correlation between independent variables.
resultsThe ULT adherence rate among gout patients was 31.6%. Multivariate binary logistic regression analysis revealed that smoking and alcohol consumption were independently associated with poor ULT adherence. Concurrent hypertension, concurrent diabetes, frequency of follow-up visits (> 3 times/year), confidence in maintaining serum uric acid within the normal range, awareness that the target serum uric acid level for ULT is 360 μmol/L, awareness that urate-lowering drugs should be taken long-term, and awareness that increased low-fat dairy intake benefits gout treatment were independently associated with good ULT adherence.
conclusionAdherence to ULT in Southwest China remains suboptimal but is higher than previously reported rates in other Chinese regions. We identified several modifiable factors-particularly disease knowledge, follow-up frequency, and lifestyle habits-that represent actionable targets for interventions to improve gout management in this underserved population. Key Points • The current status of ULT adherence among gout patients is suboptimal, and no existing surveys have examined ULT adherence rates among gout patients in Southwest China. • Our research findings indicated that the ULT adherence rate among gout patients was 31.6%. • Smoking and alcohol consumption were negatively associated with ULT adherence, whereas comorbid hypertension, diabetes, follow-up frequency exceeding three times per year, confidence, and gout-related knowledge were positively associated with improved ULT adherence.
Indexed as
Identifiers
42337134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.